For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Sequus Pharmaceuticals, Inc.

USPTO Granted Patents = 15

Trademarks = 1

Forward Citations = 1,133

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Francis J Martin (11 out of 55 patents)

Samuel Zalipsky (9 out of 43 patents)

Martin C Woodle (4 out of 13 patents)

4. Shi Kun Huang (3 out of 19 patents)

5. Theresa M Allen (3 out of 16 patents)

6. Yechezkel Barenholz (2 out of 57 patents)

7. Bei Jin (2 out of 3 patents)

8. Edwin Kiyoshi Oto (2 out of 2 patents)

9. Mohammad Hassanipour (2 out of 2 patents)

10. Karen Reis (2 out of 2 patents)

11. Robert M Abra (2 out of 12 patents)

12. Paul S Uster (2 out of 6 patents)

13. Danilo D Lasic (1 out of 5 patents)

14. Irma Ajm Bakker-Woudenberg (1 out of 1 patent)

15. Josh Gittelman (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 6326353 - Enhanced circulation effector composition and method (2001-12-04),

2. 6316024 - Therapeutic liposome composition and method of preparation (2001-11-13),

3. 6224903 - Polymer-lipid conjugate for fusion of target membranes (2001-05-01),

4. 6180134 - Enhanced ciruclation effector composition and method (2001-01-30),

5. 6133026 - Condensed plasmid-liposome complex for transfection (2000-10-17),

6. 6126966 - Liposomes containing a cisplatin compound (2000-10-03),

7. 6056973 - Therapeutic liposome composition and method of preparation (2000-05-02),

8. 6043094 - Therapeutic liposome composition and method (2000-03-28),

9. 5972379 - Liposome composition and method for administering a quinolone (1999-10-26),

10. 5945122 - Liposomes containing a cisplatin compound (1999-08-31),

11. 5891468 - Fusogenic liposome compositions and method (1999-04-06),

12. 5851818 - Condensed plasmid-liposome complex for transfection (1998-12-22),

13. 5843473 - Method of treatment of infected tissues (1998-12-01),

14. 5631018 - Lipid-polymer conjugates and liposomes (1997-05-20),

15. 5527528 - Solid-tumor treatment method (1996-06-18),

Sequus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for rare and orphan diseases. With a strong commitment to improving patient outcomes, Sequus is dedicated to bringing novel treatments to market. The company's pipeline includes promising candidates for a range of conditions, including genetic disorders and rare cancers. Sequus Pharmaceuticals aims to make a meaningful impact in the lives of patients worldwide through its cutting-edge research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#77 in Menlo Park, CA

#4,873 in California

#20,436 in US

#38,730 in the World

Menlo Park, CA, United States of America

Sequus Pharmaceuticals, Inc.

Forward Citations = 1,133

16 inventors:

Francis J Martin (11 out of 55 patents)

Samuel Zalipsky (9 out of 43 patents)

Martin C Woodle (4 out of 13 patents)

4. Shi Kun Huang (3 out of 19 patents)

5. Theresa M Allen (3 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…